Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies. [electronic resource]
Producer: 20130516Description: 299-316 p. digitalISSN:- 1179-2019
- Animals
- Antineoplastic Agents -- pharmacology
- Child
- Hematologic Neoplasms -- drug therapy
- Humans
- Lymphoproliferative Disorders -- drug therapy
- Molecular Targeted Therapy
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphoinositide-3 Kinase Inhibitors
- Proto-Oncogene Proteins c-akt -- antagonists & inhibitors
- Signal Transduction
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.